We are live on
!
Find out more
GPA
GSB Podium Advisors Portfolio holdings
AUM
$85K
1-Year Est. Return
50.58%
This Fund
S&P 500
This Quarter
Est. Return
-5.21%
1 Year Est. Return
-50.58%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.77M
AUM Growth
–
Cap. Flow
+$2.97M
Cap. Flow
% of AUM
107.37%
Top 10 Holdings %
Top 10 Hldgs %
81.95%
Holding
14
New
14
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$291K |
| 2 |
Abbott
ABT
|
+$290K |
| 3 |
Clean Harbors
CLH
|
+$258K |
| 4 |
PPG Industries
PPG
|
+$247K |
| 5 |
Bristol-Myers Squibb
BMY
|
+$222K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.96% |
| 2 | Materials | 8.81% |
| 3 | Industrials | 8.45% |
| 4 | Consumer Staples | 7.65% |
| 5 | Utilities | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Abbott
ABT
$175B
| $276K | 9.96% |
+7,901
| New | +$290K |
|
|
2
Eli Lilly
LLY
$1.05T
| $263K | 9.49% |
+5,357
| New | +$291K |
|
|
3
PPG Industries
PPG
$26.2B
| $244K | 8.81% |
+3,332
| New | +$247K |
|
|
4
Clean Harbors
CLH
$16.4B
| $234K | 8.45% |
+4,628
| New | +$258K |
|
|
5
Bristol-Myers Squibb
BMY
$124B
| $229K | 8.27% |
+5,122
| New | +$222K |
|
6
Altria Group
MO
$124B
| $212K | 7.65% |
+6,045
| New | +$217K |
|
|
CTRX
7
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $207K | 7.47% |
+4,253
| New | +$222K |
|
8
New Jersey Resources
NJR
$5.91B
| $203K | 7.33% |
+9,782
| New | +$221K |
|
9
Morgan Stanley
MS
$339B
| $202K | 7.29% |
+8,252
| New | +$196K |
|
|
CPWR
10
DELISTED
COMPUWARE CORP
CPWR
| $200K | 7.22% |
+20,134
| New | +$220K |
|
11
Corning
GLW
$133B
| $197K | 7.11% |
+13,832
| New | +$201K |
|
12
Ironwood Pharmaceuticals
IRWD
$635M
| $145K | 5.23% |
+17,385
| New | +$211K |
|
|
ATML
13
DELISTED
ATMEL CORP
ATML
| $79K | 2.85% |
+10,807
| New | +$76.2K |
|
|
ANR
14
DELISTED
Alpha Natural Resources Inc
ANR
| $79K | 2.85% |
+15,027
| New | +$102K |
|
Similar funds
CC
SS
SG
PAG
SONJCPFB
NSAA
RC
GCP
GSB Podium Advisors's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for GSB Podium Advisors, which disclosed 14 positions worth $2.77M. Its ten largest holdings account for 82% of the portfolio.
Its largest position is Eli Lilly: 5,357 shares worth $263K.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, followed by Materials and Industrials.
- GSB Podium Advisors's largest Q2 2013 buy was Eli Lilly: 5,357 shares worth $263K.
- GSB Podium Advisors's ten largest holdings make up 82% of its $2.77M portfolio in Q2 2013.
- GSB Podium Advisors disclosed 14 positions in Q2 2013, its first 13F filing on record.
Based on GSB Podium Advisors's 13F filing for Q2 2013, filed 14 Aug 2013.